Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of Twice Daily vs Once Daily Lamivudine and Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV Infection

NCT01982396 is registered in ClinicalTrials.gov with PENTA Foundation as lead sponsor.

NCT NCT01982396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of Twice Daily vs Once Daily Lamivudine and Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV Infection
Lead sponsor
PENTA Foundation
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2003
Completion date
March 31, 2004
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection